Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.

Saved in:
Bibliographic Details
Title: Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study.
Authors: Ang J; Kirby Institute, UNSW, Sydney, NSW, Australia., Hajarizadeh B; Kirby Institute, UNSW, Sydney, NSW, Australia., Tillakeratne S; Kirby Institute, UNSW, Sydney, NSW, Australia., Dore GJ; Kirby Institute, UNSW, Sydney, NSW, Australia., Treloar C; Centre for Social Research in Health, UNSW, Sydney, 2052, NSW, Australia., Amin J; Macquarie University, Sydney, NSW, Australia., van Dyk J; Kirby Institute, UNSW, Sydney, NSW, Australia., Degenhardt L; National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia., Applegate T; Kirby Institute, UNSW, Sydney, NSW, Australia., Dunlop A; Drug & Alcohol Clinical Services, Hunter New England Health, & University of Newcastle, Newcastle, NSW, Australia; Drug & Alcohol Clinical Research & Improvement, St Leonards, NSW, Australia., Fraser C; Cool Aid Community Health Center, Victoria, BC, Canada., Conway B; Vancouver Infectious Diseases Centre, Vancouver, BC, Canada., Wong A; Department of Medicine, University of Saskatchewan, Regina, SK, Canada., Fuchs D; ID Clinic, Saskatchewan Health Authority, Regina, SK, Canada., Powis J; Michael Garron Hospital, Toronto, ON, Canada., Mason K; South Riverdale Community Health Centre, Toronto, ON, Canada., Gane EJ; University of Auckland, Auckland, New Zealand., Weltman M; Department of Gastroenterology and Hepatology, Nepean Hospital, Kingswood, Australia; Nepean Clinical School, University of Sydney, Kingswood, Australia., Read P; Kirby Institute, UNSW, Sydney, NSW, Australia; Kirketon Road Centre, South Eastern Local Health District, Sydney, Australia., Martinello M; Kirby Institute, UNSW, Sydney, NSW, Australia; Blacktown and Mt Druitt Hospital, Western Sydney Local Health District, Blacktown, NSW, Australia., Rowe E; Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia; The University of Adelaide, Adelaide, SA, Australia., Baker DA; East Sydney Doctors, Sydney, Australia., Wade A; Mid North Coast Liver Clinic, Mid North Coast Local Health District, Coffs Harbour, 2450, NSW, Australia; Drug and Alcohol Services, Mid North Coast Local Health District, Coffs Harbour, 2450, NSW, Australia., Matthews G; Kirby Institute, UNSW, Sydney, NSW, Australia., Lafferty L; Kirby Institute, UNSW, Sydney, NSW, Australia., Lloyd A; Kirby Institute, UNSW, Sydney, NSW, Australia., Grebely J; Kirby Institute, UNSW, Sydney, NSW, Australia., Cunningham EB; Kirby Institute, UNSW, Sydney, NSW, Australia. Electronic address: ecunningham@kirby.unsw.edu.au.
Source: The International journal on drug policy [Int J Drug Policy] 2025 Sep; Vol. 143, pp. 104859. Date of Electronic Publication: 2025 Jun 18.
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9014759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4758 (Electronic) Linking ISSN: 09553959 NLM ISO Abbreviation: Int J Drug Policy Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-4758
DOI:10.1016/j.drugpo.2025.104859